ADORA2A and neoplasm: Although the expression of CD39 has not yet been correlated with tumor behavior or stage in patients, CD39 is overexpressed in some human tumor cells and co-culture of CD39+ tumor cells with activated CD4+ and CD8+ T cells suppressed T cell proliferation, which was abrogated in the presence of CD39-blocking antibody or A2AR inhibitor (89).